Study of Stenotrophomonas maltophilia in Cystic Fibrosis Patients
Author Information
Author(s): Pompilio Arianna, Pomponio Stefano, Crocetta Valentina, Gherardi Giovanni, Verginelli Fabio, Fiscarelli Ersilia, Dicuonzo Giordano, Savini Vincenzo, D'Antonio Domenico, Di Bonaventura Giovanni
Primary Institution: Center of Excellence on Aging, 'G. d'Annunzio' University Foundation
Hypothesis
What are the phenotypic and genotypic differences between Stenotrophomonas maltophilia isolates from cystic fibrosis and non-cystic fibrosis patients?
Conclusion
Cystic fibrosis isolates of Stenotrophomonas maltophilia show significant phenotypic differences compared to non-cystic fibrosis isolates, suggesting adaptation mechanisms in the hostile CF lung environment.
Supporting Evidence
- CF isolates showed a significantly lower ability to form biofilm compared to non-CF isolates.
- Sequential isogenic strains from the same CF patient displayed phenotypic variations over time.
- CF isolates had a higher mean generation time than non-CF isolates.
Takeaway
This study looked at bacteria from sick kids with cystic fibrosis and found that the bacteria behave differently than those from other patients, which might help them survive better in the sick kids' lungs.
Methodology
The study examined 98 isolates of S. maltophilia from clinical and environmental sources for their phenotypic and genotypic traits, including biofilm formation and virulence in a mouse model.
Potential Biases
Potential bias in strain selection from specific clinical settings may affect generalizability.
Limitations
The study may not fully represent all strains of S. maltophilia due to the specific patient population and environmental sources sampled.
Participant Demographics
41 isolates from cystic fibrosis patients and 47 from non-cystic fibrosis patients.
Statistical Information
P-Value
p<0.03
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website